SCHEMBL11348184

SCHEMBL11348184

O=C(C=Cc1ccc(Cl)cc1)c1ccc(O)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 10/20 1.00
CXCL12 P48061 2/20 1.00
F3 P13726 2/20 0.82
MAOA P21397 5/20 0.73
CYP1B1 Q16678 2/20 0.72
ABCG2 Q9UNQ0 1/20 0.72
MAPT P10636 3/20 0.70
RAB9A P51151 3/20 0.70
ESR1 P03372 1/20 0.70
ESR2 Q92731 1/20 0.70
POLB P06746 1/20 0.70
CYP3A4 P08684 2/20 0.69
HSPD1 P10809 2/20 0.69
HSPE1 P61604 2/20 0.69
KMT2A Q03164 2/20 0.69
PKM P14618 1/20 0.69
NFKB1 P19838 1/20 0.69
NFKB2 Q00653 1/20 0.69
RELA Q04206 1/20 0.69
MEN1 O00255 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9630034 1.00 MAOB (1.00) MAOBCXCL12F3MAOACYP1B1
SCHEMBL25221687 1.00 MAOB (1.00) MAOBCXCL12F3MAOACYP1B1
SCHEMBL11348180 1.00 MAOB (1.00) MAOBCXCL12F3MAOACYP1B1
SCHEMBL25201115 1.00 MAOB (1.00) MAOBCXCL12F3MAOACYP1B1
SCHEMBL9630031 1.00 MAOB (1.00) MAOBCXCL12F3MAOACYP1B1
4',4-Dichlorochalcone SCHEMBL659211 0.93 MAOB (0.86) MAOBCXCL12F3MAOACYP1B1
4',4-Dichlorochalcone SCHEMBL659210 0.93 MAOB (0.86) MAOBCXCL12F3MAOACYP1B1
4',4-Dichlorochalcone SCHEMBL11819262 0.91 MAOB (0.83) MAOBCXCL12F3MAOACYP1B1
4',4-Dichlorochalcone SCHEMBL11819608 0.91 MAOB (0.83) MAOBCXCL12F3MAOACYP1B1
4',4-Dichlorochalcone SCHEMBL11819257 0.91 MAOB (0.83) MAOBCXCL12F3MAOACYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116217461-B Chalcone derivative containing indole structure and preparation method and application thereof 贵州大学 2024-10-18 CN disclosed
CN-116283789-B Pyridazine-containing chalcone derivative and preparation method and application thereof 贵州大学 2024-09-03 CN disclosed
CN-116120256-B Chalcone compound containing thiazole oxime ether and preparation method and application thereof 贵州大学 2024-05-24 CN disclosed
CN-116283789-A Pyridazine-containing chalcone derivative and preparation method and application thereof 贵州大学 2023-06-23 CN disclosed
CN-116217461-A Chalcone derivative containing indole structure and preparation method and application thereof 贵州大学 2023-06-06 CN disclosed
CN-116120256-A Chalcone compound containing thiazole oxime ether and preparation method and application thereof 贵州大学 2023-05-16 CN disclosed
CN-109293616-B Coumarin-containing chalcone derivatives, and preparation method and application thereof 贵州大学 2022-06-21 CN disclosed
CN-109251186-B Chalcone derivative containing benzothiazole, and preparation method and application thereof 贵州大学 2022-04-19 CN disclosed
CN-109265332-B Polyhydroxy chalcone compound and application thereof 北京理工大学 2020-11-13 CN disclosed
US-9512087-B2 Hybrid molecules containing pharmacophores of fluconazole as antifungal agents and their preparation COUNCIL FOR SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2016-12-06 US disclosed
EP-2721014-B1 HYBRID MOLECULES CONTAINING PHARMACOPHORES OF FLUCONAZOLE AS ANTIFUNGAL AGENTS AND THEIR PREPARATION FDC LTD (IN) 2016-10-26 EP disclosed
US-20130303579-A1 HYBRID MOLECULES CONTAINING PHARMACOPHORES OF FLUCONAZOLE AS ANTIFUNGAL AGENTS AND THEIR PREPARATION COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2013-11-14 US disclosed
US-4279930-A Process for treating inflammation THE UPJOHN COMPANY (US) 1981-07-21 US disclosed
US-3931152-A ANTITUBERCULAR AMERICAN CYANAMID COMPANY (US) 1976-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130303579-A1 HYBRID MOLECULES CONTAINING PHARMACOPHORES OF FLUCONAZOLE AS ANTIFUNGAL AGENTS AND THEIR PREPARATION ERG28, CYP51A1, CYP2F1 MAOB 1679/4885CXCL12 979/4885F3 671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.